CR Bard Inc., BCR is in the exchange NYSE and its industry is Medical Instruments & Supplies in the sector of Healthcare. Based in USA, CR Bard Inc., BCR has a market cap of 16892.67. Since its IPO date on the 4/6/1983, CR Bard Inc., BCR performance year to date is 21.30%. Today CR Bard Inc., BCR has gained 0.56%, with a current price of 230.24.
Ownership of the company is 0.50% for insider ownership while institutional ownership is 91.10%. The management of the company have seen the company have a payout ratio of *TBA. Return of assets are at *TBA, with return on investment at 6.40%.
In terms of debt levels and profit levels, CR Bard Inc., BCR is seeing a long-term debt/equity of 0.78. While Total debt/equity is 1.14. With a profit margin of *TBA, this is combined with a gross margin of 62.20%, and operating margin of *TBA. CR Bard Inc. ability to meet debt levels, with a current ratio of 1.5, while the quick ratio is 1.2.
For the last year CR Bard Inc., BCR has seen a EPS growth of -52.90%. A performance for the year of 22.55%. The 52-week high is -3.73%, and the 52-week low is 34.18%. The average volume for CR Bard Inc., BCR is 181428.
With a target price of 232.62, can CR Bard Inc., BCR reach this target? Looking at the value indicators of CR Bard Inc., BCR. CR Bard Inc. has a P/E of 101.4 and a forward P/E of 20.38. Perhaps the more useful indicator than P/E, is PEG which has a value of 9.39. CR Bard Inc. also has a P/S and a P/B of 4.87 and 11.6 respectively. For P/cash, CR Bard Inc. has a value of 22.08, while it is *TBA for P/free cash flow.
At the current price of 230.24, CR Bard Inc. has a dividend yield of 0.45%. We see a return on equity of *TBA.
Looking more long-term CR Bard Inc., is projected to get an EPS growth for the next five years of 10.80%. In the short-term an EPS growth of 10.74% in the next year is forecasted. This is after a EPS growth of -52.90% for this year and for the last five years a -19.80% growth has been seen.